Molecular and Clinical characteristics of ROS1 Fusion Variants in ROS1-rearranged Cancers: A Defined Role of Fusion Partners and Breakpoints of ROS1.

Jeong JS, Shin Y, Yoon S, Kim D, Sampson J, Bayliss R, Choi J

Open source

DOI
10.1016/j.ejca.2025.116091
Published
2025 Dec 9
Container
European journal of cancer (Oxford, England : 1990)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2025.116091,
  title = {Molecular and Clinical characteristics of ROS1 Fusion Variants in ROS1-rearranged Cancers: A Defined Role of Fusion Partners and Breakpoints of ROS1.},
  author = {Jeong JS and Shin Y and Yoon S and Kim D and Sampson J and Bayliss R and Choi J},
  year = {2025},
  journal = {European journal of cancer (Oxford, England : 1990)},
  doi = {10.1016/j.ejca.2025.116091},
  url = {https://doi.org/10.1016/j.ejca.2025.116091}
}

RIS

TY  - JOUR
TI  - Molecular and Clinical characteristics of ROS1 Fusion Variants in ROS1-rearranged Cancers: A Defined Role of Fusion Partners and Breakpoints of ROS1.
AU  - Jeong JS
AU  - Shin Y
AU  - Yoon S
AU  - Kim D
AU  - Sampson J
AU  - Bayliss R
AU  - Choi J
PY  - 2025
JO  - European journal of cancer (Oxford, England : 1990)
DO  - 10.1016/j.ejca.2025.116091
UR  - https://doi.org/10.1016/j.ejca.2025.116091
ER  - 

APA

JS, J., Y, S., S, Y., D, K., J, S., R, B., & J, C. (2025). Molecular and Clinical characteristics of ROS1 Fusion Variants in ROS1-rearranged Cancers: A Defined Role of Fusion Partners and Breakpoints of ROS1.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2025.116091

Source records